Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × Biopsy × 1 year × Clear all

Sponsor

Conditions

Neoplasm Metastasis 43 Leukemia, Myeloid, Acute 40 Multiple Myeloma 37 Prostatic Neoplasms 29 Breast Neoplasms 29 Lung Neoplasms 24 Leukemia, Lymphocytic, Chronic, B-Cell 22 Colorectal Neoplasms 22 Lymphoma 20 Myelodysplastic Syndromes 19 Triple Negative Breast Neoplasms 18 Pancreatic Neoplasms 18 Ovarian Neoplasms 18 Lymphoma, Large B-Cell, Diffuse 18 Carcinoma, Non-Small-Cell Lung 17 Melanoma 15 Leukemia, Myelomonocytic, Chronic 13 Fallopian Tube Neoplasms 13 Carcinoma, Renal Cell 13 Burkitt Lymphoma 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Lymphoma, Follicular 12 Neuroblastoma 11 Glioma 11 Sarcoma 10 Neoplasms 10 Myeloproliferative Disorders 10 Lymphoma, Non-Hodgkin 10 Endometrial Neoplasms 9 Stomach Neoplasms 8

Interventions

Nivolumab 6 Ipilimumab 5 Cisplatin 5 atezolizumab 4 Carboplatin 4 Etoposide 3 gallium Ga 68 dotatate 2 dostarlimab 2 Temozolomide 2 Positron Emission Tomography Computed Tomography 2 Paclitaxel 2 Magnetic Resonance Imaging 2 Immunoglobulin G 2 Drug Therapy 2 Disulfides 2 zimberelimab 1 tivozanib 1 repotrectinib 1 pralsetinib 1 pembrolizumab 1 niraparib 1 lutetium Lu 177 dotatate 1 iadademstat 1 durvalumab 1 cabozantinib 1 budigalimab 1 berzosertib 1 belinostat 1 Topotecan 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡